Skip to main content

Peer Review reports

From: Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation

Original Submission
22 Nov 2017 Submitted Original manuscript
30 Aug 2017 Reviewed Reviewer Report - Chun-ru Chien
10 Sep 2017 Reviewed Reviewer Report - Edward Wilson
24 Jan 2018 Reviewed Reviewer Report - Rei Goto
3 Apr 2018 Reviewed Reviewer Report - Christine Kohn
2 Jun 2018 Author responded Author comments - Valesca Retèl
Resubmission - Version 2
2 Jun 2018 Submitted Manuscript version 2
3 Jul 2018 Reviewed Reviewer Report - Rei Goto
24 Aug 2018 Author responded Author comments - Valesca Retèl
Resubmission - Version 3
24 Aug 2018 Submitted Manuscript version 3
Publishing
3 Sep 2018 Editorially accepted
15 Sep 2018 Article published 10.1186/s12885-018-4788-5

You can find further information about peer review here.

Back to article page